NBA executives reportedly believe Los Angeles Lakers small forward Brandon Ingram's trade value has taken a hit due to the blood clots he is dealing with, according to Brian Windhorst of ESPN.
Ingram is done for the season after he was diagnosed with Deep Vein Thrombosis (DVT) in his right shoulder. It was news that no one wanted to hear.
Based on a sampling of NBA executives around the league the past few days, many believe Ingram's value has taken a real hit with this development. It feels dirty to discuss this as Ingram begins his treatment, but this is not happening in a vacuum.
DVT is a blood clot and it's usually treated by blood thinners.
Players aren’t allowed to play while using blood thinners. Chris Bosh had to end his NBA career because he was using blood thinners to treat his blood clots.
Brandon Ingram is only 21 years old. While it's good his blood clots were caught early by doctors, this is still a very scary situation the swingman is dealing with.
Ingram finished this season averaging 18.3 points, 5.1 rebounds and 3.0 assists per game while shooting 49.7 percent from the floor, 33.0 percent from beyond the arc and 67.5 percent from the free-throw line.
The Lakers are widely expected to try and trade for New Orleans Pelicans superstar power forward Anthony Davis again this summer. Ingram was reportedly part of LA's trade package at the February trade deadline.
Follow Us
Subscribe